Sept 18, 2013 (Grafton, WI) – Cedarburg Hauser Pharmaceuticals (CHP) announces the improvement of its Active Pharmaceutical Ingredient (API) plant in Grafton, WI. These upgrades are a continuation of a long-term capital improvement initiative that results from an increased demand for the contract manufacturing of commercial APIs.
“Our customer’s demand for Cedarburg Hauser commercial APIs continues to grow; upgrading our facilities are a must as we grow with our customers” stated Cedarburg Hauser CEO Tony Laughrey. “We will continue to upgrade and expand our facilities, ensuring supply for our customers.”
The upgraded facilities are expected to facilitate in a 20-25% increase in API production. Improvements to the plant include the addition of a 30 ton process chiller, an additional 200 kilowatt backup generator and an industrial vacuum pump. CHP has also tripled its filtration capacity through the addition of new, large Aurora Filters.
“The upgrades to our manufacturing facility are all about operational efficiency” says John Flahive, Director of Operations. “With these improvements we are able to increase our functional capacity by approximately 20%, allowing us to produce more material in a shorter amount of time for our clients.”
About Cedarburg Hauser Pharmaceuticals
Cedarburg Hauser Pharmaceuticals is an experienced, contract development and manufacturing organization (CDMO), specializing in small molecule active pharmaceutical ingredients (API) and pharmaceutical intermediates. Cedarburg Hauser leverages a talented group of scientists and supporting staff, as well as a centralized approach to project management, to ensure on-time and on-budget completion of projects involving the development, scale-up, and manufacturing of complex APIs.